Funding for Luxturna following MSAC recommendation
Luxturna has become the first gene therapy to receive government funding in Australia, in a landmark decision that will see ...
Tag: gene therapy
Novartis targets GA gene therapy in Gyroscope Therapeutics deal
Novartis has announced it is acquiring Gyroscope Therapeutics, the UK-based company behind an investigational dry ADM gene therapy that is ...
Sydney surgeon details first Luxturna gene therapy allowing patient to see stars
The vitreoretinal surgeon who performed Australia’s first Luxturna gene therapy has described the intricacy of the procedure, while hailing the ...
Tasmanian centre joins race for CRISPR blindness cures
In 2016, at his home RANZCO scientific branch meeting in Tasmania, preeminent ophthalmic genetics expert Professor Alex Hewitt presented on ...
Siblings treated with Luxturna gene therapy in Australian first (video included)
Teenage siblings from Sydney with an inherited retinal disease have become the first in Australia to receive the Luxturna ocular ...
Australian gene therapy researchers ‘reprogramming’ cells to restore sight
Melbourne researchers are developing a new gene therapy they hope will “switch on sight” by regenerating light-sensing photoreceptor cells in ...
Building Australia’s gene therapy capability
The rapidly evolving field of gene therapy offers a unique opportunity for Australian eye surgeons and scientists to join forces ...
Rewriting eye disease: Are we ready for gene therapies?
In 2020, ophthalmology became the first medical field in Australia to secure approval for a gene therapy. The one-off treatment ...
Gene therapy trial for dry AMD under way in Australia
Australia’s first clinical trials of an investigational gene therapy for dry age-related macular degeneration (AMD) has commenced at the Centre ...
Aussie professor’s gene therapy technique improved ‘optic nerve activity’
The managing director of one of Australia’s pre-eminent eye research institutions is a leading scientist behind experiments on mice that ...